Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

White and yellow dots indicate severe female hair loss in dark skin.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

A man with HIV had hair loss due to syphilis, which improved after penicillin treatment.

Alopecia areata can regrow hair in a pattern similar to androgenetic alopecia.

The document concludes that a unique target-like hair regrowth pattern in alopecia areata may be more common than thought and should be properly identified.

Alopecia areata in infants may be more common than previously thought.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

PRP more effective than minoxidil 5% for treating alopecia areata.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata involves immune response and gene changes affecting hair loss.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.